Pathophysiology of Crohn's disease inflammation and recurrence.

L Petagna, A Antonelli, C Ganini, V Bellato, M Campanelli, A Divizia, C Efrati, M Franceschilli, A M Guida, S Ingallinella, F Montagnese, B Sensi, L Siragusa, G S Sica
Author Information
  1. L Petagna: Department of Surgical Science, University Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. ORCID
  2. A Antonelli: Department of Surgical Science, University Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. ORCID
  3. C Ganini: Torvergata Oncoscience Research Centre of Excellence, TOR, Department of Experimental Medicine, University Tor Vergata, Rome, Italy. ORCID
  4. V Bellato: Department of Surgical Science, University Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. ORCID
  5. M Campanelli: Department of Surgical Science, University Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. ORCID
  6. A Divizia: Department of Surgical Science, University Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. ORCID
  7. C Efrati: Ospedale Israelitico, Department of Gastroenterology, Rome, Italy.
  8. M Franceschilli: Department of Surgical Science, University Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. ORCID
  9. A M Guida: Department of Surgical Science, University Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. ORCID
  10. S Ingallinella: Department of Surgical Science, University Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. ORCID
  11. F Montagnese: Nuovo Ospedale dei Castelli, Endoscopy Unit, Rome, Italy.
  12. B Sensi: Department of Surgical Science, University Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. ORCID
  13. L Siragusa: Department of Surgical Science, University Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. ORCID
  14. G S Sica: Department of Surgical Science, University Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. sigisica@gmail.com. ORCID

Abstract

Chron's Disease is a chronic inflammatory intestinal disease, first described at the beginning of the last century. The disease is characterized by the alternation of periods of flares and remissions influenced by a complex pathogenesis in which inflammation plays a key role. Crohn's disease evolution is mediated by a complex alteration of the inflammatory response which is characterized by alterations of the innate immunity of the intestinal mucosa barrier together with a remodeling of the extracellular matrix through the expression of metalloproteins and increased adhesion molecules expression, such as MAcCAM-1. This reshaped microenvironment enhances leucocytes migration in the sites of inflammation, promoting a T1 response, through the production of cytokines such as IL-12 and TNF-α. IL-12 itself and IL-23 have been targeted for the medical treatment of CD. Giving the limited success of medical therapies, the treatment of the disease is invariably surgical. This review will highlight the role of inflammation in CD and describe the surgical approaches for the prevention of the almost inevitable recurrence.

Keywords

References

  1. Dig Dis Sci. 2014 Jul;59(7):1544-51 [PMID: 24500450]
  2. Dis Colon Rectum. 2015 Nov;58(11):1021-36 [PMID: 26445174]
  3. J Gastrointest Surg. 2012 Jan;16(1):209-17 [PMID: 21909847]
  4. Adv Surg. 1999;32:135-68 [PMID: 9891742]
  5. Langenbecks Arch Surg. 2020 May;405(3):357-358 [PMID: 32390097]
  6. Biol Direct. 2018 Oct 12;13(1):22 [PMID: 30621760]
  7. Colorectal Dis. 2015 Mar;17(3):225-34 [PMID: 25307174]
  8. World J Gastroenterol. 2014 Jan 7;20(1):6-21 [PMID: 24415853]
  9. Biol Direct. 2018 May 22;13(1):10 [PMID: 29789016]
  10. Curr Opin Gastroenterol. 2016 Jul;32(4):267-73 [PMID: 27115218]
  11. J Crohns Colitis. 2018 Nov 9;12(10):1139-1150 [PMID: 29309546]
  12. Ann Surg. 2000 Sep;232(3):401-8 [PMID: 10973390]
  13. J Crohns Colitis. 2019 Mar 26;13(3):285-293 [PMID: 30203027]
  14. Colorectal Dis. 2016 Feb;18(2):214-5 [PMID: 26748779]
  15. Ann Surg. 2020 Aug;272(2):210-217 [PMID: 32675483]
  16. Am J Physiol. 1997 Oct;273(4):G769-75 [PMID: 9357817]
  17. World J Gastroenterol. 2013 Apr 28;19(16):2445-8 [PMID: 23674844]
  18. Dis Colon Rectum. 2005 Apr;48(4):749-57 [PMID: 15719191]
  19. Inflamm Bowel Dis. 2017 Mar;23(3):461-472 [PMID: 28146003]
  20. Colorectal Dis. 2020 Jun;22(6):645-646 [PMID: 32348620]
  21. J Gastrointest Surg. 2012 Jul;16(7):1412-6 [PMID: 22580840]
  22. Gastroenterol Hepatol. 2018 Mar;41(3):205-221 [PMID: 29357999]
  23. Ann Surg. 2020 Jan;271(1):e1-e2 [PMID: 31860550]
  24. Mucosal Immunol. 2011 Mar;4(2):239-44 [PMID: 20944558]
  25. PLoS One. 2015 May 07;10(5):e0126291 [PMID: 25950701]
  26. Nat Immunol. 2019 Aug;20(8):970-979 [PMID: 31235952]
  27. J Crohns Colitis. 2010 Sep;4(3):319-28 [PMID: 21122521]
  28. Gastroenterol Clin North Am. 2004 Jun;33(2):347-60, x [PMID: 15177543]
  29. Am J Med. 1975 Aug;59(2):262-8 [PMID: 1155482]
  30. Am J Gastroenterol. 2011 Apr;106(4):661-73 [PMID: 21407187]
  31. Gastroenterology. 2005 Apr;128(4):856-61 [PMID: 15825069]
  32. Aliment Pharmacol Ther. 2015 Jun;41(11):1055-65 [PMID: 25864873]
  33. Br J Surg. 1992 Sep;79(9):955-8 [PMID: 1422768]
  34. J Gastrointest Surg. 2016 Apr;20(4):783-90 [PMID: 26696531]
  35. Biol Direct. 2019 Aug 16;14(1):13 [PMID: 31420049]
  36. Biol Direct. 2019 Aug 23;14(1):16 [PMID: 31443736]
  37. Ann R Coll Surg Engl. 2019 May;101(5):313-317 [PMID: 30855162]
  38. Dig Surg. 2015;32(1):39-44 [PMID: 25678306]
  39. Dig Liver Dis. 2008 Jul;40 Suppl 2:S265-70 [PMID: 18598999]
  40. Nat Rev Immunol. 2013 May;13(5):309-20 [PMID: 23598650]
  41. J Crohns Colitis. 2014 Oct;8(10):1217-21 [PMID: 24630485]
  42. Nat Rev Gastroenterol Hepatol. 2016 Jan;13(1):13-27 [PMID: 26627550]
  43. Dig Liver Dis. 2016 May;48(5):489-494 [PMID: 26905749]
  44. Updates Surg. 2020 Sep;72(3):773-780 [PMID: 32185677]
  45. J Immunol. 2014 Jun 15;192(12):6083-91 [PMID: 24835396]
  46. J Gastrointest Surg. 2012 Oct;16(10):1976-80 [PMID: 22539032]
  47. J Gastrointest Surg. 2008 Jun;12(6):1094-102 [PMID: 18027061]
  48. Chirurg. 2019 Feb;90(2):131-136 [PMID: 29931381]
  49. Aliment Pharmacol Ther. 2014 Jun;39(12):1349-62 [PMID: 24749763]
  50. J Clin Gastroenterol. 2011 Aug;45(7):599-601 [PMID: 21224737]
  51. World J Gastroenterol. 2011 Nov 7;17(41):4602-6 [PMID: 22147966]
  52. Trials. 2020 Feb 21;21(1):210 [PMID: 32085793]
  53. Gut. 2011 Apr;60(4):553-62 [PMID: 21115545]
  54. Oncotarget. 2015 Apr 30;6(12):9908-23 [PMID: 25839161]
  55. J Gastrointest Surg. 2019 Feb;23(2):312-319 [PMID: 30353491]
  56. Am J Gastroenterol. 2018 Apr;113(4):576-583 [PMID: 29610509]
  57. Biol Direct. 2018 Oct 26;13(1):24 [PMID: 30621755]
  58. Transplant Proc. 2004 Mar;36(2):283-5 [PMID: 15050134]
  59. Biol Direct. 2019 Jul 24;14(1):11 [PMID: 31340852]
  60. Tech Coloproctol. 2020 Feb;24(2):105-126 [PMID: 31983044]
  61. Inflamm Bowel Dis. 2018 Apr 23;24(5):977-988 [PMID: 29688470]
  62. Gastroenterology. 1951 Nov;19(3):414-23 [PMID: 14887839]
  63. Am J Surg. 1978 Jan;135(1):86-90 [PMID: 623378]
  64. Medicine (Baltimore). 2018 Apr;97(15):e0315 [PMID: 29642162]
  65. J Crohns Colitis. 2020 Jan 1;14(1):4-22 [PMID: 31711158]
  66. Dig Dis Sci. 2001 Jan;46(1):128-32 [PMID: 11270776]
  67. Gastroenterol Hepatol. 2017 Aug - Sep;40(7):472-483 [PMID: 28606755]
  68. Gut. 2013 Jun;62(6):852-62 [PMID: 22543156]
  69. Lancet. 1991 Sep 28;338(8770):771-4 [PMID: 1681159]
  70. Immunity. 2013 Jan 24;38(1):187-97 [PMID: 23260195]
  71. Oncotarget. 2017 Dec 15;9(3):3432-3445 [PMID: 29423057]
  72. J Autoimmun. 2019 Sep;103:102281 [PMID: 31171476]
  73. Inflamm Bowel Dis. 2019 Feb 21;25(3):421-426 [PMID: 30346528]
  74. Dis Colon Rectum. 2011 May;54(5):586-92 [PMID: 21471760]
  75. Ann Surg. 1996 Oct;224(4):563-71; discussion 571-3 [PMID: 8857860]
  76. Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1143-1147 [PMID: 30024490]
  77. Biol Direct. 2019 Feb 26;14(1):5 [PMID: 30808378]
  78. Gastroenterology. 1998 Feb;114(2):262-7 [PMID: 9453485]
  79. Biol Direct. 2019 Aug 20;14(1):15 [PMID: 31429791]
  80. Gastroenterology. 2009 Nov;137(5):1736-45 [PMID: 19632232]
  81. Inflamm Bowel Dis. 2019 Jan 10;25(2):226-234 [PMID: 29920595]
  82. J Crohns Colitis. 2016 Apr;10(4):437-42 [PMID: 26674959]
  83. Biol Direct. 2018 Apr 3;13(1):5 [PMID: 29615097]
  84. Ann R Coll Surg Engl. 1982 Jul;64(4):229-33 [PMID: 7092090]
  85. Mucosal Immunol. 2013 Mar;6(2):244-55 [PMID: 22785229]
  86. Curr Opin Gastroenterol. 2014 Nov;30(6):559-65 [PMID: 25188546]
  87. Br J Surg. 1977 Jul;64(7):496-8 [PMID: 922310]
  88. Tech Coloproctol. 2020 May;24(5):397-419 [PMID: 32124113]
  89. Tech Coloproctol. 2020 May;24(5):421-448 [PMID: 32172396]
  90. Curr Allergy Asthma Rep. 2004 Jan;4(1):83-9 [PMID: 14680627]
  91. Cell Death Discov. 2016 May 23;2:16032 [PMID: 27551522]
  92. Dig Surg. 2000;17(5):451-3 [PMID: 11124547]
  93. Gastroenterology. 1990 Oct;99(4):956-63 [PMID: 2394349]
  94. Dig Liver Dis. 2018 Jul;50(7):653-660 [PMID: 29610019]
  95. Expert Rev Clin Immunol. 2018 Mar;14(3):179-189 [PMID: 29406811]
  96. Gastroenterol Res Pract. 2020 Feb 28;2020:6019435 [PMID: 32190040]
  97. Dis Colon Rectum. 1999 Aug;42(8):979-88 [PMID: 10458118]

MeSH Term

Crohn Disease
Humans
Immunity, Innate
Inflammation
Recurrence

Word Cloud

Created with Highcharts 10.0.0diseaseinflammationinflammatoryrecurrenceintestinalcharacterizedcomplexroleCrohn'sresponseexpressionIL-12medicaltreatmentCDsurgicalCrohn’sChron'sDiseasechronicfirstdescribedbeginninglastcenturyalternationperiodsflaresremissionsinfluencedpathogenesisplayskeyevolutionmediatedalterationalterationsinnateimmunitymucosabarriertogetherremodelingextracellularmatrixmetalloproteinsincreasedadhesionmoleculesMAcCAM-1reshapedmicroenvironmentenhancesleucocytesmigrationsitespromotingT1productioncytokinesTNF-αIL-23targetedGivinglimitedsuccesstherapiesinvariablyreviewwillhighlightdescribeapproachespreventionalmostinevitablePathophysiologyIntestinaldiseasesSurgery

Similar Articles

Cited By